Customs brokers are still wishing for guidance from CBP on the in-transit exemptions mentioned in the April 2 executive order on reciprocal tariffs, according to remarks made during the April 17 bi-weekly ACE support call hosted by CBP.
Effective April 21, transportation and logistics firm DHL expects to temporarily suspend the collection and shipping of business-to-consumer shipments to private individuals in the U.S. where the declared customs value exceeds $800, according to an online notice.
The three judges assigned to the case challenging President Donald Trump's use of the International Emergency Economic Powers Act -- Jane Restani, Gary Katzmann and Timothy Reif -- may be poised to rein in the administration's use of the act to impose tariffs, various attorneys told us. Based on their prior jurisprudence and professional backgrounds, the attorneys said, it seems likely the trio may pare back Trump's tariff-setting authority, though it's ultimately unclear to what extent.
The Office of the U.S. Trade Representative is planning a phased-in approach to assessing fees on foreign-built vessels calling at U.S. ports, according to an April 17 announcement unveiling the results of its year-long Section 301 investigation.
Many pharmaceutical products sold in the U.S. could have significant exposure to forced labor from their China-based supply chains, according to a report from risk management company Exiger.
The International Trade Commission published notices in the April 17 Federal Register on the following antidumping and countervailing duty (AD/CVD) injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
The Commerce Department published notices in the Federal Register April 17 on the following antidumping and countervailing duty (AD/CVD) proceedings (any notices that announce changes to AD/CVD rates, scope, affected firms or effective dates will be detailed in another ITT article):
The Consumer Product Safety Commission announced the following voluntary recalls April 17:
On April 16, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Foreign-Trade Zones Board issued the following notices April 17: